Still, some studies led to a controversial idea regarding the systemic administration of DNAse I as it has also been shown to accelerate tissue-type plasminogen activator (tPA)-mediated thrombolysis in human coronary disease; based on the idea that NETs have a clot-stabilizing effect in thrombi formation [249]. Here, PLAT is linked to coronary artery disorder.